Table 2. Patient characteristics and comorbidities by mortality.
ALD: Alcohol liver disease; CLD: Chronic liver disease; COPD: Chronic obstructive pulmonary disease; CXR: Chest X-ray; DMx1: Diabetes mellitus type 1; DMx2: Diabetes mellitus type 2; Frailty: Dalhousie Frailty (Rockwood) score of 4 or more classified as frail; IHD: Ischemic heart disease; ILD: Interstitial lung disease; IQR: Interquartile range; N: Number of cases; PE: Pulmonary embolism.
| All patients | Positive patients | ||||||
| Variable | Alive | Deceased | P-value | Alive | Deceased | P-value | |
| N | N = 584 | N = 158 | N = 74 | N = 38 | |||
| Age | Years | 66.1 (20.0) | 78.9 (12.1) | <0.001 | 66.4 (18.6) | 79.7 (11.1) | <0.001 |
| Male Sex | % (N) | 46.8% (273) | 58.2% (92) | 0.01 | 52.7% (39) | 63.2% (24) | 0.29 |
| Ever smoker | % (N) | 0.4% (2) | 25.6% (40) | <0.001 | 0% (0) | 48.7% (18) | <0.001 |
| CXR infiltrates | % (N) | 30.5% (178) | 63.3% (100) | <0.001 | 52.7% (39) | 63.2% (24) | 0.29 |
| Comorbidities | |||||||
| DMx1 | % (N) | 0.4% (2) | 1.3% (2) | 0.21 | 1.4% (1) | 0 (0) | 1.00 |
| DMx2 | % (N) | 0.2% (1) | 13.6% (21) | <0.001 | 0% (0) | 16.2% (6) | 0.001 |
| Diarrhea | % (N) | 12.2% (71) | 12.0% (19) | 0.96 | 25.7% (19) | 36.8% (14) | 0.22 |
| IHD | % (N) | 6.2% (35) | 65.4% (102) | <0.001 | 4.2% (3) | 78.4% (29) | <0.001 |
| Asthma/COPD/ILD | % (N) | 2.8% (16) | 44.9% (70) | <0.001 | 1.4% (1) | 59.5% (22) | <0.001 |
| Hypertension | % (N) | 4.6% (26) | 37.2% (58) | <0.001 | 2.8% (2) | 51.4% (19) | <0.001 |
| Dementia | % (N) | 4.1% (23) | 32.1% (50) | <0.001 | 5.6% (4) | 48.7% (18) | <0.001 |
| Frailty | % (N) | 4.3% (24) | 47.4% (74) | <0.001 | 2.8% (2) | 62.2% (23) | <0.001 |
| ALD-CLD | % (N) | 0 (0%) | 7.1% (11) | <0.001 | 0% (0) | 5.4% (2) | 0.11 |
| Malignancy | % (N) | 0 (0%) | 20.5% (32) | <0.001 | 0% (0) | 43.2% (16) | <0.001 |
| PE | % (N) | 0 (0%) | 6.5% (10) | <0.001 | 0% (0) | 10.8% (4) | 0.012 |
| Lymphocyte count* | 109/L | 1.22 [0.76-1.76] | 0.76 [0.52-1.09] | <0.001 | 1.17 [0.72-1.63] | 0.76 [0.58-1.25] | 0.057 |
| Lymphocyte count <1.5x109/L | % (N) | 66.1% (386) | 87.3% (138) | <0.001 | 71.6% (53) | 81.6% (31) | 0.36 |
| Covid swab positive | % (N) | 12.7% (74) | 24.1% (38) | <0.001 | - | - | - |